Altamira Therapeutics to Report Bentrio Clinical Data, in House Dust Mite and Grass Pollen Allergic Rhinitis, at Feb. 25 AAAAI Annual Meet-ing

Author's Avatar
Feb 14, 2023
  • House dust mite study shows statistically significant reduction in symptoms vs. no protection
  • Grass pollen study shows faster onset of action and superior efficacy ratings by patients
  • Bentrio® shows wider nasal cavity distribution, for 3.5 x more time, vs saline spray